InTandem Capital Partners-backed Vivo Infusion completed the acquisition of Specialty Infusion.

InTandem Capital Partners-backed Vivo Infusion, a provider of ambulatory infusion services, completed the acquisition of Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services. Financial terms were not disclosed. “We are thrilled to welcome the Specialty Infusion team to the Vivo family. Specialty Infusion has built a market-leading ambulatory infusion business by identifying an unmet market need and choosing to prioritize the needs of their patients by delivering a unique model for infusion care that they knew to be superior. This is the promise of the ambulatory infusion center experience, and we are delighted to be partners with Elan, Jake and the entire Specialty Infusion team who recognize the same promise that we do here at Vivo,” Chris Reef, Vivo Infusion Chief Executive Officer.